. 2014 Oct;21(10):564–568. doi: 10.1101/lm.036012.114
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first 12 months after the full-issue publication date (see http://learnmem.cshlp.org/site/misc/terms.xhtml). After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.
Table 3.
HDAC inhibitors as therapies for neurodegenerative diseases
